Phibro Animal Health (NASDAQ:PAHC) Lowered to Buy Rating by StockNews.com

StockNews.com lowered shares of Phibro Animal Health (NASDAQ:PAHC) from a strong-buy rating to a buy rating in a research report released on Friday morning.

A number of other research firms have also issued reports on PAHC. JPMorgan Chase & Co. started coverage on Phibro Animal Health in a report on Tuesday, September 10th. They issued a “neutral” rating and a $22.00 target price for the company. Bank of America raised their price objective on Phibro Animal Health from $13.00 to $15.00 and gave the stock an “underperform” rating in a research report on Friday, August 30th. Morgan Stanley upped their target price on Phibro Animal Health from $20.00 to $25.00 and gave the company an “equal weight” rating in a report on Tuesday, December 17th. Finally, Barclays raised their price target on shares of Phibro Animal Health from $13.00 to $20.00 and gave the stock an “underweight” rating in a report on Tuesday, November 12th. Two analysts have rated the stock with a sell rating, two have given a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat, Phibro Animal Health presently has an average rating of “Hold” and an average price target of $20.50.

Phibro Animal Health Stock Performance

PAHC opened at $21.05 on Friday. Phibro Animal Health has a fifty-two week low of $10.03 and a fifty-two week high of $25.98. The business has a fifty day simple moving average of $23.29 and a 200-day simple moving average of $20.89. The company has a quick ratio of 1.69, a current ratio of 3.23 and a debt-to-equity ratio of 1.81. The firm has a market cap of $852.59 million, a PE ratio of 48.95, a P/E/G ratio of 0.58 and a beta of 0.51.

Phibro Animal Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, December 18th. Stockholders of record on Wednesday, November 27th were paid a dividend of $0.12 per share. The ex-dividend date of this dividend was Wednesday, November 27th. This represents a $0.48 annualized dividend and a dividend yield of 2.28%. Phibro Animal Health’s dividend payout ratio (DPR) is 111.63%.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in PAHC. Acadian Asset Management LLC boosted its holdings in shares of Phibro Animal Health by 6.3% during the 2nd quarter. Acadian Asset Management LLC now owns 717,506 shares of the company’s stock worth $12,027,000 after buying an additional 42,299 shares during the period. American Century Companies Inc. increased its position in Phibro Animal Health by 119.6% in the 2nd quarter. American Century Companies Inc. now owns 347,191 shares of the company’s stock worth $5,822,000 after buying an additional 189,068 shares during the period. Dimensional Fund Advisors LP lifted its holdings in shares of Phibro Animal Health by 5.7% during the second quarter. Dimensional Fund Advisors LP now owns 775,470 shares of the company’s stock worth $13,005,000 after buying an additional 42,086 shares during the last quarter. Sofinnova Investments Inc. bought a new stake in shares of Phibro Animal Health in the second quarter valued at approximately $3,975,000. Finally, Hsbc Holdings PLC acquired a new stake in shares of Phibro Animal Health in the second quarter worth $238,000. Institutional investors and hedge funds own 99.34% of the company’s stock.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.